ROSSI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 5.764
AS - Asia 4.756
EU - Europa 3.302
SA - Sud America 653
AF - Africa 200
Continente sconosciuto - Info sul continente non disponibili 170
OC - Oceania 9
Totale 14.854
Nazione #
US - Stati Uniti d'America 5.613
SG - Singapore 1.708
CN - Cina 1.375
VN - Vietnam 680
IE - Irlanda 568
IT - Italia 537
BR - Brasile 521
SE - Svezia 514
FI - Finlandia 454
HK - Hong Kong 362
DE - Germania 312
UA - Ucraina 248
FR - Francia 178
BD - Bangladesh 148
NL - Olanda 143
TR - Turchia 136
ZA - Sudafrica 134
GB - Regno Unito 92
CA - Canada 89
IN - India 69
RU - Federazione Russa 63
AR - Argentina 54
AT - Austria 44
IQ - Iraq 37
ID - Indonesia 36
MX - Messico 35
BE - Belgio 34
KR - Corea 34
ES - Italia 30
JP - Giappone 25
CZ - Repubblica Ceca 21
MA - Marocco 19
EC - Ecuador 18
PL - Polonia 18
PK - Pakistan 16
TH - Thailandia 14
CO - Colombia 13
PY - Paraguay 13
PE - Perù 12
PT - Portogallo 12
MY - Malesia 11
UZ - Uzbekistan 11
EG - Egitto 10
PH - Filippine 10
AE - Emirati Arabi Uniti 9
EU - Europa 9
TW - Taiwan 9
AZ - Azerbaigian 8
JO - Giordania 8
KZ - Kazakistan 8
VE - Venezuela 8
AU - Australia 7
CR - Costa Rica 7
SA - Arabia Saudita 7
CI - Costa d'Avorio 6
KE - Kenya 6
NP - Nepal 6
RO - Romania 6
CL - Cile 5
DZ - Algeria 5
IR - Iran 5
LB - Libano 5
PA - Panama 5
UY - Uruguay 5
ET - Etiopia 4
IL - Israele 4
JM - Giamaica 4
LT - Lituania 4
PS - Palestinian Territory 4
SN - Senegal 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
HU - Ungheria 3
NG - Nigeria 3
TN - Tunisia 3
AM - Armenia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
RS - Serbia 2
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 14.680
Città #
Singapore 877
Ashburn 726
Chandler 613
Dublin 566
San Jose 514
Santa Clara 425
Hong Kong 345
Beijing 327
Jacksonville 310
Dallas 246
Council Bluffs 240
Ho Chi Minh City 222
Dearborn 212
Ann Arbor 162
Boardman 151
Hanoi 150
Parma 139
Nanjing 132
Johannesburg 122
Los Angeles 109
Izmir 104
Princeton 103
Lauterbourg 98
Shanghai 88
New York 80
Wilmington 76
San Mateo 71
Hefei 68
Helsinki 67
Shenyang 61
Munich 60
Nanchang 59
Columbus 51
Toronto 50
Milan 46
Seattle 44
Buffalo 41
Bremen 40
São Paulo 40
Moscow 35
Hebei 34
Brussels 33
The Dalles 33
Vienna 33
Jinan 32
Woodbridge 32
Bologna 31
Da Nang 31
Guangzhou 31
Brooklyn 28
Changsha 26
Jiaxing 26
Kunming 26
Haiphong 25
Seoul 25
Tianjin 24
Jakarta 23
Des Moines 22
Frankfurt am Main 20
Rome 20
Brno 18
Houston 18
Rio de Janeiro 18
Tokyo 18
Chicago 17
Turin 17
Amsterdam 16
Falls Church 15
Norwalk 15
Orem 15
Phoenix 15
Baghdad 14
Fremont 14
London 14
Nuremberg 14
Turku 14
Montreal 13
Warsaw 13
Denver 12
Grafing 12
Stockholm 12
Brasília 11
Zhengzhou 11
Ankara 10
Boston 10
Can Tho 10
San Francisco 10
Taizhou 10
Atlanta 9
Belo Horizonte 9
Campinas 9
Hải Dương 9
Manchester 9
Poplar 9
Pune 9
Verona 9
Baku 8
Charlotte 8
Dong Ket 8
Hangzhou 8
Totale 8.915
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 247
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 228
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 206
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 206
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 205
Opportunity and challenges of nasal powders: Drug formulation and delivery 205
Sex-specific cardiac electrophysiological remodeling influences the susceptibility to arrhythmias in elderly rats 199
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 184
Alginate containing formulations: are they all the same? 181
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors 178
MULTILAYERED PHARMACEUTICAL FORMULATION 176
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 175
Aerodynamic performance of jet nebulizers marketed in Germany 174
GASTRO-RESISTANT DELAYED RELEASE PHARMACEUTICAL FORM 172
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 172
A new assembled delivery system of Clarithromycin and Amoxicillin for Helicobacter Pylori therapy 171
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 167
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 165
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 165
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 163
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 162
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 162
Assemblage of drug release modules: Effect of module shape and position in the assembled systems on floating behavior and release rate 161
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 161
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 160
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 158
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 153
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 153
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 151
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 150
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 150
Thermal degradation and melting point determination of diclofenac 148
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 148
Interaction of pharmaceutical hydrates with supoercritical CO2: solubility, solid state and chemical modifications 147
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 146
Development of solid lipid microparticles by melt-emulsification/spray-drying processes as carriers for pulmonary drug delivery 145
Assembled delivery system for the release of two pulses of esomeprazole in combination with sucralfate 140
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 137
Primary microparticles and agglomerates of morphine for nasal insufflation 137
Current status of ATP-ase proton pump inhibitor complexation with cyclodextrins 134
Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia 132
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 132
Thermal Properties of Binary Mixtures of b-Cyclodextrin with Carbamazepine Polymorphs 131
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 130
Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide 130
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 130
Thermal and Morfological characterisation of micronized acetylsalicylic acid powders prepared by rapid expansion of a supercritical solution 129
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 129
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 129
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 129
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 128
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 127
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 126
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 126
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 125
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 125
Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets 125
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction 124
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 124
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 122
In vitro comparison of medicinal products based on alginic acid claimed to protect the esophagus wall and physically prevent acid reflux 121
Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid 121
Bauhinia ungulata L.: Medicinal Utilization, Botanical Aspects, Biological Properties and Chemical Constitution Reported in the Literature 119
Inclusion Properties, Polymorphism and Desolvation Kinetics in aNew 2-Pyridyl Iminophenol Compound with 1D Nanochannels 119
Layered lipid microcapsules for mesalazine delayed-release in children 118
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 118
Polymorphism of rac-5,6-diisobutyryloxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene hydrochloride (CHF 1035). I. Thermal, spectroscopic, and X-ray diffraction properties 118
Swellable and rigid matrices: Controlled Release Matrices with Cellulose Ethers 118
New salt of cysteamine for the preparation of highly respirable particles 117
Hesperidin Gastroresistant Microparticles by Spray-Drying: Preparation, Characterization, and Dissolution Profiles 116
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 115
Particles and powders: Tools of innovation for non-invasive drug administration 114
High Respirable Insulin Dry Powder for Pulmonary Administration 113
Phase diagrams in the binary system 113
Soft agglomerates of mesalazine multiparticles for colonic delivery in pediatric patients 113
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 113
Direct powder extrusion (DPE) 3D-printing of mini-tablets for preclinical studies in rodents 112
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 110
Solid state characterization of paracetamol metastable polymorphs formed in binary mixtures with hydroxypropylmethylcellulose 110
Lecithin/Chitosan Based Nanosystem for Tamoxifen Citrate Oral Delivery 110
Polymorphism of rac-5,6-Diisobutyryloxy-2-Methylamino-1,2,3,4-Tetrahydro-Napthalene Hydrochloride (CHF 1035). I. Thermal, Spectroscopic, and X-ray Diffraction Properties 110
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers 109
Pantoprazole Cyclodextrin Inclusion Complexes 106
Multi-kinetics and site-specific oral delivery system of artemether and clindamycin for malaria theraphy 104
In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery 104
Le Basi del Calcolo Farmaceutico 102
New Farnesane Sesquiterpenes from Lactarius Porninsis 101
Polymorphism in Cocoa Butter Under Shear 101
Nasal Powders of Morphine Microcrystal Agglomerates 99
Influence of tamoxifen citrate loading on lecithin/chitosan nanoparticles 98
PURE INSULIN HIGHLY RESPIRABLE POWDERS FOR INHALATION 98
New Protoilludane Sesquiterpenes from Lactarius Violascens” 97
Thermal behavior of paracetamol-polymeric excipients mixtures 97
Pharmacokinetics evaluation of soft agglomerates for prompt delivery of enteric pantoprazole-loaded microparticles 96
Acai Oil-Based Organogel Containing Hyaluronic Acid for Topical Cosmetic: In Vitro and Ex Vivo Assessment 95
Understanding and enhancing density distribution inside tableted Dome Matrix modules 95
The Development of Insulin Dry Powder Blends for Pulmonary Administration 95
Conversion of carbamazepine polymorphs in supercritical CO2 93
Nasal Powders of Morphine Microcrystal Agglomerates 90
Quercetin Microspheres by Solvent Evaporation: Preparation, Characterization and Release Behavior 90
Totale 13.583
Categoria #
all - tutte 51.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022592 0 13 11 28 25 25 78 89 27 42 47 207
2022/20232.154 222 246 146 167 189 236 19 142 701 19 52 15
2023/2024800 34 88 24 55 67 187 63 47 25 46 67 97
2024/20252.605 73 132 144 163 285 341 110 104 293 236 240 484
2025/20265.547 564 518 729 417 828 272 600 135 666 393 288 137
2026/2027327 142 185 0 0 0 0 0 0 0 0 0 0
Totale 14.854